Tag: #Global Trends

Amgen has announced that a subcutaneous version of its blockbuster drug Tepezza—a treatment for thyroid eye disease (TED)—successfully met both... Read more

Sanofi has announced Phase 2 trial results for Lunsekimig, a bispecific biologic targeting two well-known drivers of inflammation: TSLP and... Read more

In a strategic move to enhance patient convenience and treatment adherence, Vertex Pharmaceuticals has entered into a licensing agreement to... Read more

Following a sharp decline in demand for the HPV vaccine (Gardasil) in China, Merck & Co. and its domestic distribution... Read more

On April 1, 2026, the U.S. Food and Drug Administration (FDA) approved Foundayo (orforglipron), a once-daily obesity pill developed by... Read more

In a significant legal victory for the pharmaceutical industry, a Brussels court has ordered Poland and Romania to pay a... Read more

In a move reflecting a sharp strategic shift following the pandemic era, German biotech firm BioNTech has confirmed it will... Read more

Following a White House announcement on April 2, 2026, the Trump administration has introduced a 100% tariff on patented pharmaceutical... Read more

The European Commission (EC) has granted conditional marketing authorization for Sanofi’s Rezurock (belumosudil) to treat chronic graft-versus-host disease (GVHD). The... Read more